Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia

被引:137
作者
Wen, Y [1 ]
Yang, SH [1 ]
Liu, R [1 ]
Perez, E [1 ]
Yi, KD [1 ]
Koulen, P [1 ]
Simpkins, JW [1 ]
机构
[1] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA
关键词
stroke; estrogen; NF kappa B; neuroprotection; post-ischemic inflammation;
D O I
10.1016/j.brainres.2004.02.019
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The protective effects of estrogens have been widely reported in a number of animal and cell culture models, but the molecular mechanisms of this potent neuroprotective activity are not well understood. Both in vitro and in vivo studies indicate that in the central nervous system and peripheral tissues, estrogen treatment reduces cytokine production and inflammatory responses. Nuclear factor-kappa B (NFkappaB) plays an essential role in the regulation of post-ischemic inflammation, which is detrimental to recovery from an ischemic stroke. We investigated the role of NFkappaB in neuronal survival in rats that received transient middle cerebral artery (MCA) occlusion, and observed that this transient cerebral ischemia induced substantial apoptosis and inflammatory responses, including IkappaB phosphotylation, NF-kappaB activation and iNOs over-expression. 17 beta-estradio1 (E2) treatment produced strong protective effects by reducing infarct volume neuronal apoptosis and inflamtnatoty responses. These findings provide evidence for a novel molecular and cellular interaction between the sex hormone and the immunoresponsive system. These studies also provide evidence that suppression of post-ischemic inflammation may play a critical role in estrogen-mediated neuroprotection. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:147 / 154
页数:8
相关论文
共 42 条
[1]   Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study [J].
Asthana, S ;
Craft, S ;
Baker, LD ;
Raskind, MA ;
Birnbaum, RS ;
Lofgreen, CP ;
Veith, RC ;
Plymate, SR .
PSYCHONEUROENDOCRINOLOGY, 1999, 24 (06) :657-677
[2]   STIMULATION OF HIV TYPE-1 GENE-EXPRESSION AND INDUCTION OF NF-KAPPA-B (P50/P65)-BINDING ACTIVITY IN TUMOR NECROSIS FACTOR-ALPHA-TREATED HUMAN FETAL GLIAL-CELLS [J].
ATWOOD, WJ ;
TORNATORE, CS ;
TRAUB, R ;
CONANT, K ;
DREW, PD ;
MAJOR, EO .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (10) :1207-1211
[3]  
Azcoitia I, 2001, Prog Brain Res, V132, P469
[4]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[5]   Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury [J].
Berti, R ;
Williams, AJ ;
Moffett, JR ;
Hale, SL ;
Velarde, LC ;
Elliott, PJ ;
Yao, CP ;
Dave, JR ;
Tortella, FC .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (09) :1068-1079
[6]  
Carrol JE, 2000, NEUROREPORT, V11, pR1
[7]   Nuclear factor-κB activation during cerebral reperfusion:: effect of attenuation with N-acetylcysteine treatment [J].
Carroll, JE ;
Howard, EF ;
Hess, DC ;
Wakade, CG ;
Chen, Q ;
Cheng, C .
MOLECULAR BRAIN RESEARCH, 1998, 56 (1-2) :186-191
[8]   Deteriorating ischaemic stroke: cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaernic stroke [J].
Christensen, H ;
Boysen, G ;
Johannesen, HH ;
Christensen, E ;
Bendtzen, K .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 201 (1-2) :1-7
[9]   Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion - Role of neutrophil adhesion in the pathogenesis of stroke [J].
Connolly, ES ;
Winfree, CJ ;
Springer, TA ;
Naka, Y ;
Liao, H ;
Yan, SD ;
Stern, DM ;
Solomon, RA ;
GutierrezRamos, JC ;
Pinsky, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :209-216
[10]   Pathobiology of ischaemic stroke: an integrated view [J].
Dirnagl, U ;
Iadecola, C ;
Moskowitz, MA .
TRENDS IN NEUROSCIENCES, 1999, 22 (09) :391-397